{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:57:59Z","timestamp":1781621879699,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ecl.2026.01.005","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T21:14:55Z","timestamp":1770844495000},"page":"285-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary Bilateral Macronodular Adrenal Hyperplasia"],"prefix":"10.1016","volume":"55","author":[{"given":"Chrysoula","family":"Koukoula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Kyriakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos","family":"Tsagarakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra Argyro","family":"Vassiliadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2026.01.005_bib1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/jcem-24-10-947","article-title":"Cushing\u2019s syndrome: nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor","volume":"24","author":"Kirschner","year":"1964","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2026.01.005_bib2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41574-022-00718-y","article-title":"Primary bilateral macronodular adrenal hyperplasia: definitely a genetic disease","volume":"18","author":"Cavalcante","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"10.1016\/j.ecl.2026.01.005_bib3","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1158\/1078-0432.CCR-08-0106","article-title":"Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors","volume":"14","author":"Lib\u00e9","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ecl.2026.01.005_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1530\/eje.1.02324","article-title":"Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors","volume":"156","author":"Vezzosi","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.ecl.2026.01.005_bib5","doi-asserted-by":"crossref","first-page":"e2946","DOI":"10.1210\/clinem\/dgae918","article-title":"PDE11A is a phenotype modulator of primary bilateral macronodular adrenal hyperplasia: results of a 334-Patient series","volume":"110","author":"Vaduva","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ecl.2026.01.005_bib6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal Cushing\u2019s syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ecl.2026.01.005_bib7","first-page":"5534","article-title":"Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing\u2019s syndrome","volume":"86","author":"Bourdeau","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2026.01.005_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1210\/endrev\/bnac034","article-title":"Clinical, pathophysiologic, genetic, and therapeutic progress in primary bilateral macronodular adrenal hyperplasia","volume":"44","author":"Bertherat","year":"2023","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.ecl.2026.01.005_bib9","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/ERC-17-0361","article-title":"Genetics of tumors of the adrenal cortex","volume":"25","author":"Bonnet-Serrano","year":"2018","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.ecl.2026.01.005_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.beem.2018.01.003","article-title":"Aberrant G-protein coupled hormone receptor in adrenal diseases","volume":"32","author":"St-Jean","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"22","key":"10.1016\/j.ecl.2026.01.005_bib11","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with Cushing\u2019s syndrome","volume":"369","author":"Assie","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ecl.2026.01.005_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13023-025-03554-1","article-title":"The mutational landscape of ARMC5 in primary bilateral macronodular adrenal hyperplasia: an update","volume":"20","author":"Bouys","year":"2025","journal-title":"Orphanet J Rare Dis"},{"issue":"22","key":"10.1016\/j.ecl.2026.01.005_bib13","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1056\/NEJMoa1215245","article-title":"Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia","volume":"369","author":"Louiset","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ecl.2026.01.005_bib14","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1210\/jc.2014-2648","article-title":"Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma","volume":"100","author":"Elbelt","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2026.01.005_bib15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-8587(21)00236-9","article-title":"Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing\u2019s syndrome: a multicentre, retrospective, cohort study","volume":"9","author":"Chasseloup","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2026.01.005_bib16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.gim.2021.09.018","article-title":"KDM1A inactivation causes hereditary food-dependent Cushing syndrome","volume":"24","author":"Vaczlavik","year":"2022","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.ecl.2026.01.005_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ejendo\/lvaf016","article-title":"KDM1A genetic alterations, a rare cause of primary bilateral macronodular adrenal hyperplasia, strongly associated with food-dependent Cushing\u2019s syndrome: results of its systematic germline screening in 301 index cases and genotype\/phenotype correlation","volume":"192","author":"Bouys","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2026.01.005_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","article-title":"Overview of the 2022 WHO classification of adrenal cortical tumors","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"issue":"2","key":"10.1016\/j.ecl.2026.01.005_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12022-023-09751-7","article-title":"Impact of morphology in the genotype and phenotype correlation of Bilateral Macronodular Adrenocortical Disease (BMAD): a series of clinicopathologically well-characterized 35 cases","volume":"34","author":"Violon","year":"2023","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.ecl.2026.01.005_bib20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1507\/endocrj.41.429","article-title":"Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia: a case report and immunohistochemical studies","volume":"41","author":"Koizumi","year":"1994","journal-title":"Endocr J"},{"issue":"8","key":"10.1016\/j.ecl.2026.01.005_bib21","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1210\/jc.2009-0516","article-title":"Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors","volume":"94","author":"Hsiao","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ecl.2026.01.005_bib22","doi-asserted-by":"crossref","first-page":"R567","DOI":"10.1530\/ERC-19-0240","article-title":"Diagnosis and management of primary bilateral macronodular adrenal hyperplasia","volume":"26","author":"Vassiliadi","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.1016\/j.ecl.2026.01.005_bib23","doi-asserted-by":"crossref","first-page":"E926","DOI":"10.1210\/jc.2014-4204","article-title":"ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences","volume":"100","author":"Espiard","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ecl.2026.01.005_bib24","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s40618-025-02561-0","article-title":"Long-term cardiometabolic outcomes of primary bilateral macronodular adrenal hyperplasia","volume":"48","author":"Zhou","year":"2025","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"10.1016\/j.ecl.2026.01.005_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5937\/jomb0-43319","article-title":"Clinical and cardiac characteristics of primary bilateral macronodular adrenal hyperplasia","volume":"43","author":"Miao","year":"2024","journal-title":"J Med Biochem"},{"issue":"3","key":"10.1016\/j.ecl.2026.01.005_bib26","doi-asserted-by":"crossref","DOI":"10.1530\/EC-24-0664","article-title":"Bilateral macronodular adrenocortical disease: a single centre experience","volume":"14","author":"Ban","year":"2025","journal-title":"Endocr Connect"},{"issue":"2","key":"10.1016\/j.ecl.2026.01.005_bib27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1530\/EJE-12-0777","article-title":"Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics","volume":"168","author":"Morelli","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.ecl.2026.01.005_bib28","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1210\/clinem\/dgae164","article-title":"Approach to the patient with bilateral adrenal masses","volume":"109","author":"Vassiliadi","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2026.01.005_bib29","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/JC.2015-1653","article-title":"Abnormal responsiveness to dexamethasone-suppressed CRH test in patients with bilateral adrenal incidentalomas","volume":"100","author":"Vassiliadi","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ecl.2026.01.005_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1530\/ERC-20-0102","article-title":"Mass spectrometry-based steroid profiling in primary bilateral macronodular adrenocortical hyperplasia","volume":"27","author":"Hannah-Shmouni","year":"2020","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"10.1016\/j.ecl.2026.01.005_bib31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s12020-011-9490-1","article-title":"Aberrant cortisol responses to physiological stimuli in patients presenting with bilateral adrenal incidentalomas","volume":"40","author":"Vassiliadi","year":"2011","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.ecl.2026.01.005_bib32","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2026.01.005_bib33","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1530\/EJE-15-0566","article-title":"Biochemical and clinical benefits of unilateral adrenalectomy in patients with subclinical hypercortisolism and bilateral adrenal incidentalomas","volume":"173","author":"Perogamvros","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.ecl.2026.01.005_bib34","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1210\/jc.2015-2662","article-title":"Unilateral adrenalectomy as a first-line treatment of Cushing\u2019s syndrome in patients with primary bilateral macronodular adrenal hyperplasia","volume":"100","author":"Debillon","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2026.01.005_bib35","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1055\/a-0998-7884","article-title":"Unilateral adrenalectomy for primary bilateral macronodular adrenal hyperplasia: analysis of 71 cases","volume":"128","author":"Sheikh-Ahmad","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"10.1016\/j.ecl.2026.01.005_bib36","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.4158\/EP12346.CR","article-title":"Adrenocorticotropic hormone independent macronodular adrenal hyperplasia due to aberrant receptor expression: is medical treatment always an option?","volume":"19","author":"Karapanou","year":"2013","journal-title":"Endocr Pract"},{"issue":"9","key":"10.1016\/j.ecl.2026.01.005_bib37","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1210\/jc.2017-00823","article-title":"Resetting the abnormal circadian cortisol rhythm in adrenal incidentaloma patients with mild autonomous cortisol secretion","volume":"102","author":"Debono","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2026.01.005_bib38","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/clinem\/dgaf206","article-title":"Chronotherapy with once-daily osilodrostat improves cortisol rhythm, quality of life, and sleep in Cushing\u2019s syndrome","volume":"110","author":"Ferrari","year":"2025","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852926000058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852926000058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:50:40Z","timestamp":1781621440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852926000058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0889852926000058"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2026.01.005","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Bilateral Macronodular Adrenal Hyperplasia","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2026.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}